Gerresheimer AG, one of the world’s leading partners of the pharma and healthcare industry, is committed to growth in the emerging markets. It acquires a majority shareholding in the Indian company Neutral Glass & Allied Industries Pvt. Ltd. to help it achieve this aim. Having local production operations in the emerging markets is strategically significant for Gerresheimer due to the rapid growth of the pharma sectors there. Gerresheimer already has five plants in South America, seven in China and representative offices in Moscow and Mumbai, providing it with a strong presence in the emerging markets. Now it also has a modern pharma glass production facility in India.
“The Indian pharma market is gaining in international significance and it is growing at an impressive rate. Neutral Glass is a leading manufacturer of high quality glass pharmaceutical packaging products which has achieved profitable growth over recent years.
Our acquisition of a majority shareholding in Neutral Glass will help us to strengthen our position in the emerging markets and to drive our growth in India,” commented Uwe Röhrhoff, CEO of Gerresheimer AG.
Neutral Glass is a leading manufacturer of pharmaceutical primary packaging made of glass based in Mumbai with a modern moulded glass plant in Kosamba (Gujarat Province, India). Neutral Glass produces pharmaceutical primary packaging products such as glass vials for liquid medications and infusions, as well as injection bottles. Gerresheimer has acquired a 70% stake in the company from the owner family, which has retained 30% of the shares. The signing took place today, the closing is expected in short term. In the 2010/11 financial year, Neutral Glass generated annual revenues of approximately INR 1.0bn (around EUR 15m) and it has some 600 employees. Neutral Glass’s quality management systems have been certified as compliant with ISO 9001:2008.
Gerresheimer took over the leading Brazilian manufacturer of pharmaceutical plastic packaging products in March 2011. With five plants in South America, seven in China and the new plant in India, plus representative offices in Moscow and Mumbai, Gerresheimer is well represented in the fast-growing BRIC nations (Brazil, Russia, India and China). Gerresheimer’s declared objective is to double revenues in the emerging markets from EUR 100m in 2010 to EUR 200m in 2013. In addition to organic growth, acquisitions such as the Neutral Glass acquisition and the acquisition of the Brazilian company last year will play an important role in taking Gerresheimer closer to achieving its revenue growth objective.
About Neutral Glass
- Founded in 1986
- One Moulded Glass Plant in Kosamba (Gujarat),
- Head office in Mumbai, India
- Until today 100% family owned
- From today on: 70% Gerresheimer, 30% former shareholders
- Approx. 600 employees
- 4 furnaces, 12 IS lines
- Production of medium to small size glass containers for pharmaceutical (type I & III) applications: amber and flint vials and bottles for liquid oral formulations, injectables etc.
- Approx. 800 mio. bottles per year
- EN ISO 9001:2008 certified
Gerresheimer is an internationally leading manufacturer of high-quality specialty products made of glass and plastic for the global pharma and healthcare industry. Our comprehensive portfolio of products extends from pharmaceutical vials to complex drug delivery systems such as syringe systems, insulin pens and inhalers for safe medication dosage and application. Together with our partners, we develop solutions which set standards and have role model status in their respective market sectors.
Our Group realizes revenues of around one billion euros and has over 10,000 employees at 47 locations in Europe, North and South America and Asia. We use first-rate technologies, convincing innovations and targeted investments to systematically consolidate our strong market position.